MRKD trade ideas
MERCK: The guaranteed winIt is such an easy task to accumulate profits from this stock market. The process that you should follow is:
1/ To enter the market through a long position;
2/ To reinforce our position by buying once again;
3/ To close/ sell because of the lower tendency of the stock market.
The right time of each action is indicated in the chart.
The concerned traders write in comments.
MRK: Ascending TriangleAscending Triangle
Pros
ATR climbing
Descending volume
PPS above 50MA
250RSI above 50
Cons
R/R ratio below 4, not good
PPS below 200MA
200MA Flat/Descending
If confirmed
PT1 = 81,74
PT2 = 83,02
PT3 = 85,07
PT4 = 86,84
Bonus PT5 = 88,40
Bonus PT6 = 90,07
Bonus PT7 = 92,12
Technical view of Merck & CO Hello every one
Merck's stock is moving in a short-term sideways direction.
With a high volumes.
Between levels 73.4 and 84.7
Therefore it is advised to trade between the two levels.
Good luck.
$MRK key support and resistanceFirst key test will be at 75.42
Next, 73.02 and then 66.49
Price Target: 83.46, Final Price Target near all time high 92
MRK Long, 60M Demand ZoneThe Highlighted Area had been traded many times.
Buy orders and Sell orders had been filled by each other.
Once demand zone got confirmed,
This area will be treated as GAP.
Earning will not affect this trade.
Entry: 74.5 (Below 75)
Stop: 72.8; Below Demand zone
Target: 82; risk/reward=1:4
This is a trading school homework. I need few months to practice trading plan.
If you like it, thank you for your support. Please use SIM/Demo account to try it, until my trading plans get high winning rate.
Merck & CO $MRKAfter hitting 100SMA, it went down and seems that found its support which worked several times before. It may attract the buyers again
12 months Consensus Price Target: $94.21
if you find my charts useful, please leave me "like" or "comment".
Please don't trade according to the ideas, rely on your own knowledge.
Thx
Merck has upside to $82Analyst forecasts for Merck earnings came down sharply early this year, but lately they've stabilized and even ticked upward a little. Merck is still priced for an optimistic market, with forward P/E around 15 and PEG around 2-3. This is reasonable for a large cap company with 3% dividend and a great reputation, but it's not bargain pricing, exactly. A second round of lockdowns or a second wave of Covid-19 could hurt the stock again.
But as long there's no major deterioration of the macroeconomic outlook, the fair value range for Merck is about $75-82 per share. Analysts have been slow to make any forecasts for 2022 due to macroeconomic uncertainty, but I predict that the top end of the fair value range will shift upward to $87 per share once the 2022 forecasts finally come in.
Merck is oversold today on the hourly RSI and curling upward. MACD is below the signal line, but also curling upward. A few minutes ago Merck announced an FDA approval to expand the label for GARDASIL, its HPV drug. I suspect this may function as a catalyst to send Merck back upward toward $82 per share. I bought some shares after-hours, and if I can get in cheap enough, I will consider some call options tomorrow with maybe a one-month expiration.
